Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Cyberdyne's Total Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7779 vs ABT, SYK, MDT: Total Payout Ratio Comparison
For the Medical Devices subindustry, Cyberdyne's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyberdyne Total Payout Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cyberdyne's Total Payout Ratio distribution charts can be found below:
* The bar in red indicates where Cyberdyne's Total Payout Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cyberdyne (TSE:7779) has a Total Payout Ratio of 0.00 as of Aug. 19, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Cyberdyne and its competitors.
Is Cyberdyne's Total Payout Ratio too high?
Cyberdyne's current Total Payout Ratio is 0.00. Overall, Cyberdyne has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cyberdyne's Total Payout Ratio compare to ABT and SYK?
Cyberdyne's Total Payout Ratio of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Medical Devices & Instruments company?
A good Total Payout Ratio depends on the Medical Devices & Instruments industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Cyberdyne and its competitors. Cyberdyne's current Total Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyberdyne stock overvalued right now?
Based on GuruFocus' analysis, Cyberdyne (TSE:7779) is currently considered Modestly Overvalued. The stock's GF Value™ is 円194.48, compared to a current price of 円235.00 — trading 20.8% above its estimated fair value. The current Total Payout Ratio is 0.00. Cyberdyne's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For Cyberdyne (TSE:7779), the current Total Payout Ratio is 0.00 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cyberdyne (TSE:7779) Overvalued in 2026?
Based on GuruFocus' analysis, Cyberdyne stock appears to be overvalued.
The current stock price of 円235.00 is trading 20.8% above its estimated GF Value™ of 円194.48.
GuruFocus considers Cyberdyne to be Modestly Overvalued.
Key valuation signals for TSE:7779:
Total Payout Ratio: 0.00
GF Value™: 円194.48 vs. price of 円235.00 (20.8% above fair value)
No single metric tells the full story. See the TSE:7779 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cyberdyne Inc is a Japanese based company engaged in the research and development of medical welfare equipment and systems. It offers equipment and systems for rehabilitation support, body function support for elderly and disabled people, rescue support in disaster sites, entertainments, and heavy labor support in factories. Its products include Hybrid Assistive Limb (HAL) for the lower limb, single joint, lumbar, Table Interface and Cleaning Robots. In addition, it also offers services in respect to medical service and non-medical service which includes HAL therapy under medical service, and Hal fit and Robo care service under non-medical service.
76GF Score
Get the complete analysis for TSE:7779
Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7779 has been successfully added to your 
